MedTrace helps doctors diagnose critically ill patients faster and more accurately.
MedTrace Pharma has raised $19.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
MedTrace Pharma's investors include European Innovation Council, Vaekstfonden, Swisscanto Private Equity, ATP, Syddansk Innovation.
MedTrace Pharma is headquartered in Lyngby, Denmark.
MedTrace helps doctors diagnose critically ill patients faster and more accurately.
MedTrace Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MedTrace Pharma — Funding & Investors." VCBacked, September 21, 2023, https://www.vcbacked.co/company/medtrace-pharma. Accessed November 13, 2026.
VCBacked. (2023). MedTrace Pharma — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/medtrace-pharma
{{cite web |title=MedTrace Pharma — Funding & Investors |url=https://www.vcbacked.co/company/medtrace-pharma |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at MedTrace Pharma? Request a listing update